Jean‐Michel Caillaud
Institut Gustave Roussy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean‐Michel Caillaud.
Cancer | 1988
J.P. Droz; Marwane Ghosn; Gilles Piot; Christine Theodore; Jose Luis Pico; M. Hayat; Andrew Kramar; Annie Rey; P. Wibault; Bernard Court; Jean L. Perrin; Jean Paul Travagli; Dominique Bellet; Jean‐Michel Caillaud
In order to define prognostic factors for advanced stage of nonseminomatous germ cell tumors (NSGCT) of the testis, the authors reviewed 84 patients treated from 1978 through 1985. The survival rate was 51% at 3 years. Patients with elevated seric levels of human chorionic gonadotropin (HCG) and/or alpha‐fetoprotein (AFP), or the presence of an abdominal mass had significantly worse survival. Only HCG and AFP levels retained their significance when multivariate Cox analysis was performed. The probability that a patient achieves a complete remission (CR) was assessed by a function of certain patient characteristics using a multivariate logistic regression analysis. The significant variables were a function of HCG and AFP values. Since both variables are related to the CR rate and survival the authors define the obtention of a CR as a unique outcome of interest. The probability of a CR greater than 70% adequately separates the patients into two prognostic subgroups. This model currently is being used to enrole NSGCT patients in a prospective modulated clinical trial according to these prognostic factors.
Cancer | 1984
A. Leblanc; Jean‐Michel Caillaud; Olivier Hartmann; Chantal Kalifa; Françoise Flamant; Catherine Patte; Marie-France Tournade; J. Lemerle
Unusual clinical, radiologic, or histologic findings were found in 11 of 17 cases of hypercalcemia associated with childhood tumors. Four children had undifferentiated lymphoblastic lymphoma with extensive bone involvement, but no visceral or neurologic involvement. At diagnosis, four adolescents with rhabdomyosarcoma had numerous metastases, particularly in the breasts and bone marrow. Three infants had renal tumor without bone metastases. Histologically, their tumors differed from classical nephroblastoma and resembled the malignant rhabdoid tumors of the kidney. These findings allow individualization of three distinct groups of tumors with unusual features which may suggest the presence of hypercalcemia. These tumors appear to have a poor prognosis since all patients but one died of their malignancy.
Cancer | 1981
Antonino Carbone; Christian Micheau; Jean‐Michel Caillaud; Christiane Carlu
Malignant histiocytosis (MH) is a true histiocytic disorder, whose identification is still based on too broad morphologic criteria. Using routine histology, cytochemical and immunohistochemical techniques on involved lymph nodes, 15 cases of MH have been investigated. Pleomorphism and cellular atypia, phagocytosis, lack of cohesiveness between proliferating cells, sinusoidal involvement, and plasmacytic infiltrate were the most common histologic features. MGG‐stained imprints from 14 cases showed a composite tumor population mainly consisting of histiocyte‐appearing cells, poorly differentiated atypical cells, and multinucleated giant cells. These cells, irrespective of cytologic features, revealed a diffuse, moderately to strongly positive reaction with acid phosphatase and nonspecific esterase. Naphtol‐AS‐D‐chloroacetate esterase, Sudan black B, alkaline phosphatase, and β‐glucuronidase reactions were completely negative. Immunoperoxidase studies in 11 cases demonstrated that tumor cells stained positively for both kappa and lambda chains. These cells were also positive for albumin. Polytypic staining for IgG was observed in two cases, and a weak staining for lysozyme was found in two other nodes. Global results confirm the value of these studies for functional profile determination of MH proliferating cells. A combined approach using a variety of cytochemical and immunohistochemical techniques should be routinely considered in MH as useful additional studies for a more precise diagnostic definition of the disease.
Scandinavian Journal of Urology and Nephrology | 1990
Jean-Pierre Droz; P. Ruffié; Gilles Piot; Marwane Ghosn; Jean‐Michel Caillaud; Dominique Elias; Jean-Louisee Perrin; Philippe Levasseur
The authors describe the case of a patient with stage II non seminomatous germinal cell tumor of the testis with a generalized sarcoidosis. They review the existing literature and discuss the problem of diagnosis.
Virchows Archiv | 1989
J. Klijanienko; Christian Micheau; C. Carlu; Jean‐Michel Caillaud
It has been suggested that cytokeratin 13 is a useful marker of malignancy. We examined normal squamous cell epithelia, hyperplasia, dysplasias of various grades, intraepithelial neoplasia and invasive squamous cell carcinomas of the pyriform fossa using K13 and KL1. Positive staining for K13 was seen in all normal or hyperplastic benign epithelia, was inconstant in dysplasia, and intraepithelial neoplasia and carcinoma was negative. KL1 expression is constant and non significant. These results suggest that tumour cells are unable to synthesize keratin 13 a finding which may be valuable in surgical pathology.
Medical and Pediatric Oncology | 1992
Catherine Patte; Chantal Kalifa; Françoise Flamant; Olivier Hartmann; Laurence Brugières; Dominique Valteau-Couanet; Chantal Bayle; Jean‐Michel Caillaud; J. Lemerle
Archives of Otolaryngology-head & Neck Surgery | 1993
Jerzy Klijanienko; Adel K. El-Naggar; Anne Ponzio-Prion; P. Marandas; Christian Micheau; Jean‐Michel Caillaud
Diagnostic Cytopathology | 2007
Jerzy Klijanienko; Jean‐Michel Caillaud; Daniel Orbach; Hervé Brisse; Réal Lagacé; Philippe Vielh; Jérôme Couturier; Paul Fréneaux; Stamatios Theocharis; Xavier Sastre-Garau
Diagnostic Cytopathology | 2003
Jerzy Klijanienko; Jean‐Michel Caillaud; Réal Lagacé; Philippe Vielh
Diagnostic Cytopathology | 2004
Jerzy Klijanienko; Jean‐Michel Caillaud; Réal Lagacé